PURE Bioscience, Inc. (PURE)
| Market Cap | 9.81M +72.0% |
| Revenue (ttm) | 2.32M +5.3% |
| Net Income | -2.48M |
| EPS | -0.02 |
| Shares Out | 140.20M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 9,187 |
| Open | 0.0580 |
| Previous Close | 0.0700 |
| Day's Range | 0.0580 - 0.0700 |
| 52-Week Range | 0.0386 - 0.0999 |
| Beta | 0.31 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Dec 15, 2026 |
About PURE Bioscience
PURE Bioscience, Inc. develops and commercializes proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company’s technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food ... [Read more]
Financial Performance
In fiscal year 2026, PURE Bioscience's revenue was $2.32 million, an increase of 5.27% compared to the previous year's $2.20 million. Losses were -$2.48 million, 3.50% more than in 2025.
Financial StatementsNews
PURE Bioscience reports FY26 EPS (2c) vs. (2c) last year
Reports FY26 revenue $2.3M vs. $2.2M last year. Jeff Kitchell, Chief Executive Officer, stated, “We are up year-over-year despite being a challenging year, with the macro environment causing increased...
PURE Bioscience Reports Fiscal 2026 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)---- $PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company,” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) anti...
PURE Bioscience Reports Fiscal Third Quarter 2026 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)---- $PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antim...
Purecore Strengthens Technical Advisory Expertise with Nuclear Fuel Cycle and Uranium Enrichment Specialist, Ted Rygas, PhD
VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”) is pleased to announce the addition of Dr. Ted Rygas as Technic...
Purecore Announces up to $1.5 Million Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.
Purecore Announces Listing on the Frankfurt Stock Exchange
VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”) is pleased to announce that its common shares are now listed fo...
Purecore Metals Announces Field Program Commencement at the Bankier Property
VANCOUVER, British Columbia, May 28, 2026 (GLOBE NEWSWIRE) -- Purecore Metals Inc. (CSE: PURE) (“Purecore” or the “Company”) is pleased to announce HEG & Associates geoscientists have commenced boots-...
Purecore Engages HEG & Associates for its 2026 Exploration Program at the Bankier Property
VANCOUVER, British Columbia, May 21, 2026 (GLOBE NEWSWIRE) -- Purecore Metals Inc. (CSE: PURE) (“Purecore” or the “Company”) is pleased to announce that it has engaged HEG & Associates Exploration Ser...
Purecore Metals Inc. Announces Listing on the Canadian Securities Exchange Under the Symbol “PURE”
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.
PURE Bioscience Reports Fiscal Second Quarter 2026 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)---- $PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antim...
PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)---- $PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antim...
PURE Bioscience, Inc. Announces Leadership Promotions
EL CAJON, Calif.--(BUSINESS WIRE)---- $PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE” or the “Company”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobi...
PURE Bioscience Reports Fiscal 2025 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)---- $PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antim...
PURE Bioscience Partners with Bonsai for Direct-to-Customer Sales
EL CAJON, Calif.--(BUSINESS WIRE)---- $PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antim...
PURE Bioscience Reports Fiscal Third Quarter 2025 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial...
PURE Bioscience Unveils Revolutionary Membrane Treatment Solution for the Dairy and Beverage Industry
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial...
PURE Bioscience Reports Fiscal Second Quarter 2025 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial...
PURE Bioscience Announces a New Distribution Agreement With Hydrite Chemical Company
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial...
PURE Bioscience Unveils New Brand Identity
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial...
PURE Bioscience Reports Fiscal First Quarter 2025 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial...
PURE Bioscience and AFCO, a Zep Company in distribution deal for SDC products
PURE Bioscience (PURE) and AFCO, a Zep Company, have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is…
PURE Bioscience Announces Distribution Agreement with AFCO, a Zep Company
EL CAJON, Calif.--(BUSINESS WIRE)-- #AFCO--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and AFC...
PURE Bioscience Announces Distribution Agreement with Quip Laboratories
EL CAJON, Calif.--(BUSINESS WIRE)-- #AALAS--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and Qu...
PURE Bioscience Reports Fiscal 2024 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)-- #Biofilm--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, toda...
PURE Bioscience enters distribution agreement with Madison Chemical
PURE Bioscience (PURE) and Madison Chemical Co. have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. Published first o...